Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
02/2004
02/05/2004US20040024249 Hydrofluoroethers having at least one hydrogenated-OCFX'CH3 end group wherein X'=F, CF3 and their preparation process
02/05/2004US20040024153 Reduction of perfluoropolyethers containing peroxidic bonds, using gaseous hydrogen in presence of platinum, palladium or rhodium catalyst supported on metal fluoride
02/05/2004US20040023960 Mammalian metabolites of the compound 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3- (4-fluoro) phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo) methylmorpholine which is a tachykinin receptor antagonist as antiemetics
02/04/2004EP1385815A1 Process for the removal of undesired flavour and odour components from potassium lactate
02/04/2004EP1385814A1 Enantiomerically selective cyclopropanation
02/04/2004CN1473199A Method for obtaining 12-hydroxystearic acid
02/04/2004CN1473142A Method for producing poly-or monomethylol alkanoic acids
02/01/2004CA2435920A1 Hydrofluoroethers having at least one hydrogenated -ocfx'ch3, end group wherein x'=f, cf3 and their preparation process
01/2004
01/29/2004WO2003040080A3 Lipoxin a4 analogs
01/29/2004US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
01/29/2004US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections
01/29/2004US20040019156 Comprises metal bromide oxidation catalysts, in liquid phase using acetic acid as solvent; waste treatment
01/29/2004US20040019072 Dimer-selective RXR modulators and methods for their use
01/29/2004US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives
01/29/2004US20040019033 Mandelic acid derivatives and their use as throbin inhibitors
01/29/2004US20040018948 Skin care cosmetic methods of sebum control using carboxyalkylates of branched alcohols and/or alkoxylates thereof
01/28/2004CN1470493A Poly epoxy butanedioic acid and its salt preparing method
01/28/2004CN1470492A Preparation of optical pure D-malic acid
01/28/2004CN1136183C Process for producing optically active mevalonolactone compound
01/27/2004US6683208 For use in preparation of optically active carboxylic acids and/or derivatives
01/27/2004US6683206 Stereoselective addition to benzaldehydes; regioselective elimination to form 3-r-2-r3-propenic acid esters; hydrolysis; hydrogenation using ruthenium, rhodium or iridium catalyst
01/27/2004US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity
01/22/2004WO2004007439A1 Biaryl derivatives
01/22/2004WO2004006883A1 Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
01/22/2004WO2003049690A3 Hiv integrase inhibitors
01/22/2004WO2003024390A3 Hydroxyeicosenoic acid analogs
01/22/2004US20040014184 Method for obtaining 12-hydroxystearic acid
01/22/2004US20040013631 Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
01/22/2004US20040013630 Skin care cosmetic compositions containing carboxyalkylates of branched alcohols and/or alkoxylates thereof
01/21/2004CN1469858A Aspirin-triggered lipid mediators
01/21/2004CN1469857A Method of producing carboxylic acid salts
01/20/2004CA2251241C Apoptosis inhibitor
01/20/2004CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
01/15/2004WO2004005243A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives
01/15/2004WO2004005236A1 Polyene carboxylic acid derivatives, method for their production and the use thereof
01/15/2004WO2004005233A1 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
01/15/2004WO2004005229A1 Modulators of the glucocorticoid receptor
01/15/2004US20040010159 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors
01/15/2004DE10229713A1 Polyencarbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung Polyencarbonsäure derivatives, processes for their preparation and their use
01/15/2004CA2491994A1 Modulators of the glucocorticoid receptor
01/15/2004CA2490570A1 Polyene carboxylic acid derivatives, method for their production and the use thereof
01/14/2004EP1380562A1 Carboxylic acid derivative and salt thereof
01/14/2004CN1134399C Method for making bis-xylenols containing acid moieties
01/13/2004US6677473 Plasminogen activator inhibitor antagonists
01/13/2004US6677390 Photocurable composition containing iodonium salt compound
01/08/2004WO2004002947A1 Phenoxypropenylphenyl derivatives and their use as herbicides
01/08/2004WO2002098220A3 Pesticidal activity of functionalized alkenes
01/08/2004US20040006243 Reacting a phenylketone with a silylcyanide in the presence of an asymmetric catalyst to form a siloxynitrile, and reacting the siloxynitrile with a reducing agent to obtain an aldehyde and oxidizing the aldehyde, or hydrolysis of siloxynitrile
01/07/2004CN1466562A Process for producing acyl fluoride and carboxylic acid salt
01/07/2004CN1133413C Alpha-hydroxy fatty acid derivatives and cosmetic used composition for external use containing same
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/06/2004CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds
01/02/2004EP1375469A1 A process for preparing acylfluorides
01/02/2004EP1373186A1 A process for the preparation of cyclic amino acids
01/02/2004EP1372667A2 Compositions for delivering bisphosphonates
01/02/2004EP1228031B1 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives useful for the treatment of dry eye
01/02/2004EP1228026B1 15-hydroxyeicosatetraenoic acid-related compounds and methods of use
01/02/2004EP1140799B1 Novel propargylether derivatives
01/02/2004EP1124782B1 Method for racemate splitting of 2-hydroxypropionic acids
01/01/2004US20040002597 Catalytic process for the modification of carbohydrates, alcohols, aldehydes or polyhydroxy compounds
01/01/2004US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
12/2003
12/31/2003WO2004000315A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/30/2003US6670505 Process for the recovery of organic acids from aqueous solutions
12/30/2003US6670396 Aspirin-triggered lipid mediators
12/30/2003US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists
12/30/2003CA2067943C Aqueous calcium citrate compositions
12/25/2003US20030236436 Process for preparing acylfluorides
12/25/2003US20030236423 Trihydroxy polyunsaturated eicosanoids
12/25/2003US20030236305 Vision defects
12/25/2003US20030236268 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003US20030232886 For resolving racemic mixtures; chemical intermediates, drugs
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/17/2003EP1370513A1 Malic acid addition salts of terbinafine
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370509A2 Method for the production of glyceric acid
12/17/2003CN1462267A Method for producing ketocarbodylic acid derivatives
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131196C Process for rapidly racemizing naproxen methylester by microwave method
12/17/2003CN1131195C Process for synthesizing tartaric acid from cis-butene diacid
12/17/2003CN1131194C Process for preparing tartaric acid
12/11/2003WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
12/10/2003EP1369409A1 Process for preparing compounds useful as intermediates
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/10/2003EP1053219B1 Improved separation processes
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461293A Method for producing fluorine-containing compound
12/09/2003US6660770 Pesticidal activity of functionalized alkenes
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 147